Demethyllavendamycin 2-hydroxyethanamide

ID: ALA597611

Chembl Id: CHEMBL597611

PubChem CID: 46228866

Max Phase: Preclinical

Molecular Formula: C23H17N5O4

Molecular Weight: 427.42

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: Demethyllavendamycin 2-Hydroxyethanamide | CHEMBL597611|Demethyllavendamycin 2-hydroxyethanamide

Canonical SMILES:  NC1=CC(=O)c2ccc(-c3nc(C(=O)NCCO)cc4c3[nH]c3ccccc34)nc2C1=O

Standard InChI:  InChI=1S/C23H17N5O4/c24-14-10-18(30)12-5-6-16(27-20(12)22(14)31)21-19-13(11-3-1-2-4-15(11)26-19)9-17(28-21)23(32)25-7-8-29/h1-6,9-10,26,29H,7-8,24H2,(H,25,32)

Standard InChI Key:  OFKBXUGLDYFQKH-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

NQO1 Tchem Quinone reductase 1 (1746 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BE (127 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 427.42Molecular Weight (Monoisotopic): 427.1281AlogP: 1.72#Rotatable Bonds: 4
Polar Surface Area: 151.06Molecular Species: NEUTRALHBA: 7HBD: 4
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 11.82CX Basic pKa: 0.14CX LogP: 0.60CX LogD: 0.60
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.39Np Likeness Score: 0.43

References

1. Cai W, Hassani M, Karki R, Walter ED, Koelsch KH, Seradj H, Lineswala JP, Mirzaei H, York JS, Olang F, Sedighi M, Lucas JS, Eads TJ, Rose AS, Charkhzarrin S, Hermann NG, Beall HD, Behforouz M..  (2010)  Synthesis, metabolism and in vitro cytotoxicity studies on novel lavendamycin antitumor agents.,  18  (5): [PMID:20149966] [10.1016/j.bmc.2010.01.037]

Source